Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/31/2022
Financial-related Company News Digest (October 2022)
10/31/2022
Novartis Abandons US PD-1 Submission Plan for Tislelizumab
10/31/2022
NMPA Suspends Import, Sales and Use of GSK's Prostate Cancer Drug Avod...
10/31/2022
JPO Bans GSK from Participating in China's National Level Centralized ...
10/30/2022
Ascletis Pharma Ends Down After Pfizer Supply Deal Sent Stock Soaring
10/28/2022
CDE Publicizes the List of Reference Formulations for GQCE Studies (64...
10/28/2022
Recent Executive Moves
10/28/2022
Drug R&D and Product Registration News Digest October 2022 (3)
10/28/2022
XtalPi Announces Research Collaboration with Janssen
10/27/2022
NMPA Announces Package Insert Revision of Domperidone Formulations
10/27/2022
CDE Solicits Comments on Draft Work Standards for Review of Drug Clini...
10/27/2022
Salubris and Anlong Bio Enter Partnership for Small Nucleic Acid Dru...
10/27/2022
China NMPA Approval Tracker 09/2022 (PharmaDJ)
10/27/2022
Semiconductor Export Curbs Hitting China To Be Followed By Biotech and...
10/26/2022
CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
10/26/2022
NMPA Issues the Measures for the Administration of Drug Recalls (with ...
10/26/2022
WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...
10/25/2022
CDE Solicits Comments on Draft Technical Guidelines For Clinical Trial...
10/25/2022
CDE Solicits Comments on Draft Technical Guidelines for Pharmaceutical...
10/25/2022
CDE Solicits Comments on Draft Technical Guidelines for Clinical Safet...
10/25/2022
Crisis or Opportunity? Biotech Companies Are at A Crossroads in The St...
10/25/2022
Clinical Research Opportunities in China and the Path to USFDA Approva...
10/24/2022
U.S. Government Seeks to Restrict Biotechnology Cooperation with China...
10/24/2022
NASDAQ-listed BIMI Disposes Acquired Chinese Pharma Distributor
10/21/2022
CDE Solicits Comments on Draft Provisions for GLP Certification of Dru...
10/21/2022
Drug R&D and Product Registration News Digest October 2022 (2)
10/21/2022
Recent Executive Moves
10/20/2022
CDE Issues the List of Reference Formulations for GQCE Studies (61st B...
10/20/2022
IQVIA Forecasts Chinese CMDO Market to Grow 20% CAGR Before 2025
10/19/2022
Fitch: US Biomanufacturing Plan Poses Minor Risks to Chinese Pharma CD...
Page:
123
/
774
Total number of articles:
23208
:
[First]
[<<]
[121]
[122]
[123]
[124]
[125]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit